Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC28A1 | O00337 | 1/20 | 0.69 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.69 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.69 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.69 |
| ▸ | P2RY6 | Q15077 | 8/20 | 0.67 |
| ▸ | P2RY2 | P41231 | 12/20 | 0.65 |
| ▸ | P2RY4 | P51582 | 5/20 | 0.65 |
| ▸ | P2RY14 | Q15391 | 6/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28889687 | 0.91 | SLC28A1 (0.70) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL23344550 | 0.91 | SLC28A1 (0.70) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL735093 | 0.89 | SLC28A1 (0.67) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL21742397 | 0.87 | SLC28A1 (0.65) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL5846586 | 0.86 | SLC28A1 (0.74) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL425155 | 0.86 | SLC28A1 (0.74) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL6053985 | 0.86 | SLC28A1 (0.74) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL566229 | 0.85 | SLC28A1 (0.72) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL7618891 | 0.85 | SLC28A1 (0.72) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL1054387 | 0.85 | SLC28A1 (0.72) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4143293-A1 | MEASUREMENT OF NITROGEN FIXATION AND INCORPORATION | Pivot Bio, Inc. (US) | 2023-03-08 | — | — | EP | claimed |
| EP-4142477-A1 | STABLE LIQUID FORMULATIONS FOR NITROGEN-FIXING MICROORGANISMS | Pivot Bio, Inc. (US) | 2023-03-08 | — | — | EP | claimed |
| WO-2021222643-A1 | STABLE LIQUID FORMULATIONS FOR NITROGEN-FIXING MICROORGANISMS | PIVOT BIO, INC. (US) | 2021-11-04 | — | — | WO | claimed |
| WO-2021221689-A1 | MEASUREMENT OF NITROGEN FIXATION AND INCORPORATION | PIVOT BIO, INC. (US) | 2021-11-04 | — | — | WO | claimed |
| EP-4362661-A1 | GENETICALLY-ENGINEERED BACTERIAL STRAINS FOR IMPROVED FIXATION OF NITROGEN | Pivot Bio, Inc. (US) | 2024-05-08 | — | — | EP | disclosed |
| US-11767546-B2 | Enzymatic method for preparation of UDP-GlcNAc | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2023-09-26 | — | — | US | disclosed |
| US-11739358-B2 | Enzymatic method for preparation of UDP-galactose | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2023-08-29 | — | — | US | disclosed |
| US-20230263800-A1 | COMPOSITIONS AND METHODS TO PROMOTE THYMIC FUNCTION | FRED HUTCHINSON CANCER CENTER (US) | 2023-08-24 | — | — | US | disclosed |
| EP-3874055-B1 | ENZYMATIC METHOD FOR PREPARATION OF UDP-GALACTOSE | MAX PLANCK GESELLSCHAFT (DE) | 2023-06-14 | — | — | EP | disclosed |
| EP-3874056-B1 | ENZYMATIC METHOD FOR PREPARATION OF UDP-GLCNAC | MAX PLANCK GESELLSCHAFT (DE) | 2023-06-14 | — | — | EP | disclosed |
| EP-4192233-A1 | IMPROVED PLANT NITROGEN CONSISTENCY THROUGH THE SUPPLY OF WHOLE PLANT NITROGEN FROM A NITROGEN FIXING MICROBE | Pivot Bio, Inc. (US) | 2023-06-14 | — | — | EP | disclosed |
| EP-4143211-A2 | MODIFIED BACTERIAL STRAINS FOR IMPROVED FIXATION OF NITROGEN | Pivot Bio, Inc. (US) | 2023-03-08 | — | — | EP | disclosed |
| US-7425435-B2 | Corynebacterium glutamicum genes encoding phosphoenolpyruvate: sugar phosphotransferase system proteins | BASF AKTIENGESELLSCHAFT (DE) | 2008-09-16 | — | — | US | disclosed |
| US-20070082383-A1 | Expression vector comprising nucleotide sequences coding sugar metabolism and oxidative phosphorylation (SMP) proteins for enhancing production of functional heterologous polypeptides | BASF AKTIENGESELLSCHAFT (DE) | 2007-04-12 | — | — | US | disclosed |
| US-20060292674-A1 | Corynebacterium glutamicum genes encoding phosphoenolpyruvate: sugar phosphotransferase system proteins | BASF AG (DE) | 2006-12-28 | — | — | US | disclosed |
| EP-1702980-A1 | Corynebacterium glutamicum gene encoding Hpr of phosphoenolpyruvate:sugar phosphotransferase system | BASF AKTIENGESELLSCHAFT (DE) | 2006-09-20 | — | — | EP | disclosed |
| US-20060084152-A1 | Corynebacterium glutamicum genes encoding metabolic pathway proteins | BASF AKTIENGESELLSCHAFT (DE) | 2006-04-20 | — | — | US | disclosed |
| US-20050277115-A1 | Corynebacterium glutamicum genes encoding proteins involved in homeostasis and adaptation | POMPEJUS MARKUS | 2005-12-15 | — | — | US | disclosed |
| US-6831165-B1 | For drug/cosmetic/feed/food production | BASF AKTIENGESELLSCHAFT (DE) | 2004-12-14 | — | — | US | disclosed |
| US-6194141-B1 | DETECTING MODULATOR OF VIRAL PROPAGATION; INCUBATE VIRAL NUCLEOTIDE SEQUENCE MIXTURE WITH METALS, INCUBATE SECOND MIXTURE WITH MODULATOR, CALIBRATE AND COMPARE AMOUNT OF URIDINE INCORPORATED INTO TRANSCRIPTS IN BOTH MIXTURES | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK | 2001-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230263800-A1 | COMPOSITIONS AND METHODS TO PROMOTE THYMIC FUNCTION | BMP4, P2RY2, GPR39 | SLC28A1 1969/4885SLC28A2 1383/4885SLC29A1 1588/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.